We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BIOT.ST

Price
89.20
Stock movement down
-4.80 (-5.11%)
Company name
Biotage AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
7.14B
Ent value
7.83B
Price/Sales
3.37
Price/Book
1.87
Div yield
-
Div growth
-
Growth years
-
FCF payout
52.89%
Trailing P/E
27.78
Forward P/E
19.09
PEG
-
EPS growth
5.28%
1 year return
-49.60%
3 year return
-27.20%
5 year return
-2.72%
10 year return
18.60%
Last updated: 2025-04-05

DIVIDENDS

BIOT.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E27.78
Price to OCF17.63
Price to FCF29.51
Price to EBITDA12.82
EV to EBITDA14.05

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.37
Price to Book1.87
EV to Sales3.70

FINANCIALS

Per share

Loading...
Per share data
Current share count80.05M
EPS (TTM)3.21
FCF per share (TTM)3.02

Income statement

Loading...
Income statement data
Revenue (TTM)2.12B
Gross profit (TTM)1.32B
Operating income (TTM)377.00M
Net income (TTM)257.00M
EPS (TTM)3.21
EPS (1y forward)4.67

Margins

Loading...
Margins data
Gross margin (TTM)62.49%
Operating margin (TTM)17.81%
Profit margin (TTM)12.14%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash370.00M
Net receivables378.00M
Total current assets1.24B
Goodwill2.49B
Intangible assets768.00M
Property, plant and equipment313.00M
Total assets4.87B
Accounts payable69.00M
Short/Current long term debt250.00M
Total current liabilities648.00M
Total liabilities1.05B
Shareholder's equity3.81B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)405.00M
Capital expenditures (TTM)163.00M
Free cash flow (TTM)242.00M
Dividends paid (TTM)128.00M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity6.75%
Return on Assets5.28%
Return on Invested Capital6.44%
Cash Return on Invested Capital6.06%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open94.00
Daily high95.05
Daily low87.90
Daily Volume153K
All-time high289.60
1y analyst estimate202.67
Beta0.91
EPS (TTM)3.21
Dividend per share-
Ex-div date26 Apr 2024
Next earnings date24 Apr 2025

Downside potential

Loading...
Downside potential data
BIOT.STS&P500
Current price drop from All-time high-69.20%-17.56%
Highest price drop-96.91%-56.47%
Date of highest drop2 Oct 20029 Mar 2009
Avg drop from high-69.33%-11.07%
Avg time to new high100 days12 days
Max time to new high4613 days1805 days
COMPANY DETAILS
BIOT.ST (Biotage AB) company logo
Marketcap
7.14B
Marketcap category
Mid-cap
Description
Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Employees
675
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
In March 2025, the European market showed signs of resilience as the pan-European STOXX Europe 600 Index ended higher, buoyed by hopes of increased government spending despite ongoing concerns over im...
March 28, 2025
In recent weeks, the European stock market has exhibited cautious optimism, with the pan-European STOXX Europe 600 Index experiencing a modest rise amid ongoing geopolitical developments and economic ...
February 27, 2025
In February 2025, global markets are navigating a complex landscape marked by geopolitical tensions and consumer spending concerns, with major indices like the S&P 500 experiencing sharp fluctuations....
February 24, 2025
Biotage AB (BITGF) reports a 10.5% revenue increase in 2024, with significant growth in the Astrea segment despite challenges in Q4.
February 20, 2025
As global markets continue to navigate the evolving economic landscape, with U.S. stocks reaching record highs amid optimism around AI investments and potential trade deals, small-cap stocks have gene...
January 31, 2025
In a week marked by cautious Federal Reserve commentary and political uncertainty, global markets experienced notable declines, with smaller-cap indexes particularly affected. Despite these challenges...
December 25, 2024
As global markets navigate the uncertainties surrounding the incoming Trump administration's policies, key indices like the S&P 600 for small-cap stocks have experienced notable fluctuations. Amid the...
November 22, 2024
Biotage AB (BITGF) reports robust organic growth and strategic investments, despite facing production constraints and regional market pressures.
October 24, 2024
As the European Central Bank's recent interest rate cuts fuel expectations for further monetary easing, Sweden's stock market is experiencing a period of heightened investor interest. In this environm...
October 21, 2024
As global markets respond to China's stimulus measures and European indices show signs of recovery, Sweden's economic landscape is also experiencing shifts, highlighted by the Riksbank's recent intere...
October 3, 2024
Next page